Evidence map›Paper›PMID 30237263›Full record

ArticleHaematologica2018

Clonally related diffuse large B-cell lymphoma and interdigitating dendritic cell sarcoma sharing

Yotaro Ochi, Nobuhiro Hiramoto, Tetsuichi Yoshizato, Yuichiro Ono, June Takeda, Yusuke Shiozawa, Kenichi Yoshida, Nobuyuki Kakiuchi, Yuichi Shiraishi, Hiroko Tanaka and 13 more

Abstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Potential role ofFrontiers in pediatrics · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Yotaro OchiDepartment of Hematology, Kobe City Medical Center General Hospital ochi.yotaro.24v@kyoto-u.jp kvlqt1789@gmail.com.
Nobuhiro HiramotoDepartment of Hematology, Kobe City Medical Center General Hospital ochi.yotaro.24v@kyoto-u.jp kvlqt1789@gmail.com.
Tetsuichi YoshizatoDepartment of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University.
Yuichiro OnoDepartment of Hematology, Kobe City Medical Center General Hospital.
June TakedaDepartment of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University.
Yusuke ShiozawaDepartment of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University.
Kenichi YoshidaDepartment of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University.
Nobuyuki KakiuchiDepartment of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University.
Yuichi ShiraishiLaboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo.
Hiroko TanakaLaboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo.
Kenichi ChibaLaboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo.
Yasuhiro KazumaDepartment of Hematology, Kobe City Medical Center General Hospital.
Sumie TabataDepartment of Hematology, Kobe City Medical Center General Hospital.
Noboru YonetaniDepartment of Hematology, Kobe City Medical Center General Hospital.
Keiichiro UeharaDepartment of Clinical Pathology, Kobe City Medical Center General Hospital.
Daisuke YamashitaDepartment of Clinical Pathology, Kobe City Medical Center General Hospital.
Yukihiro ImaiDepartment of Clinical Pathology, Kobe City Medical Center General Hospital.
Koji NagafujiDivision of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine.
Mitsunori YamakawaDepartment of Pathological Diagnostics, Faculty of Medicine, Yamagata University, Japan.
Satoru MiyanoLaboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo.
Akifumi Takaori-KondoDepartment of Hematology and Oncology, Graduate School of Medicine, Kyoto University.
Seishi OgawaDepartment of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University.
Takayuki IshikawaDepartment of Hematology, Kobe City Medical Center General Hospital.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Translocation, GeneticDendritic Cell Sarcoma, FollicularHIV InfectionsHumansLymphoma, Large B-Cell, DiffuseMaleMiddle AgedNeoplasms, Second PrimaryProto-Oncogene Proteins c-mycMYC protein, humanProto-Oncogene Proteins c-myc

Identifiers

PMID30237263
PMCPMC6278963

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.